Results 81 to 90 of about 68,978 (241)

Direct Economic Burden of Post‐Cancer Treatment Pain Among Cancer Survivors in the United States: A Population‐Based Retrospective Longitudinal Study

open access: yesThe International Journal of Health Planning and Management, EarlyView.
ABSTRACT Purpose Post‐cancer treatment pain (PCTP) is prevalent among cancer survivors but remains understudied. It is critical to quantify PCTP prevalence over time and to estimate the resulting short and long‐term incremental healthcare expenditures (total, third‐party, and out‐of‐pocket) and out‐of‐pocket burden among cancer survivors.
Yves Paul Vincent Mbous   +3 more
wiley   +1 more source

Therapeutic targeting of chromatin alterations in leukemia and solid tumors

open access: yesInternational Journal of Cancer, EarlyView.
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner   +7 more
wiley   +1 more source

Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer

open access: yesInternational Journal of Cancer, EarlyView.
What's New? In this prospective study, the authors evaluated the discrimination capacity of 92 cancer‐related proteins as potential early detection biomarkers for endometrial cancer using blood samples from two large‐scale European population cohorts (EPIC and Janus).
Victoria Cooley   +12 more
wiley   +1 more source

Nodal involvement evaluation in advanced cervical cancer: a single institutional experience [PDF]

open access: yes, 2013
Purpose: To assess the usefulness of different imaging techniques in the detection of nodal involvement in patients with advanced cervical carcinoma.
Diestro, Maria Dolores   +5 more
core   +1 more source

Should the age range of the Dutch hrHPV‐based cervical cancer screening program be broadened? A modelling study using cohort effects

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Cervical cancer incidence in the Netherlands is increasing among women in younger birth cohorts. This raises concerns about the start and end ages of the country's human papillomavirus (HPV) screening program, which currently includes women ages 30 to 60.
Sylvia Kaljouw   +3 more
wiley   +1 more source

Targeted reactivation of the novel tumor suppressor DAPK1, an upstream regulator of p53, in high‐grade serous ovarian cancer by mRNA liposomes reduces viability and enhances drug sensitivity in preclinical models

open access: yes
Cancer Communications, EarlyView.
Monika Raab   +10 more
wiley   +1 more source

Time to pathologic diagnosis of suspicious breast lesions: An institution‐based study in five Ethiopian hospitals

open access: yesInternational Journal of Cancer, EarlyView.
What's New? The World Health Organization's Global Breast Cancer Initiative set the benchmark to diagnose breast cancer within 2 months of the first contact with a health care provider. This study analyzed the diagnostic journey of women with breast symptoms at five Ethiopian hospitals. Of the 345 women interviewed who received a diagnostic workup of a
Friedemann Rabe   +12 more
wiley   +1 more source

Indocyanine green utility in sentinel node detection for cervical cancer patients [PDF]

open access: yes, 2019
With wide implementation of screening tests for the Human Papilloma Virus, the number of diagnosed cases of premalignant or early stages of cervical cancer has increased considerably.
Bacalbașa, Nicolae   +4 more
core   +1 more source

Ascites of patients with solid tumors shows distinct inflammatory patterns

open access: yes
Cancer Communications, EarlyView.
Julia M. Berger   +19 more
wiley   +1 more source

Nationwide implementation and evaluation of the Tumor‐First workflow for genetic testing in ovarian carcinoma

open access: yesInternational Journal of Cancer, EarlyView.
What's New? The Tumor‐First workflow is a genetic testing strategy developed to detect pathogenic variants in ovarian cancer risk genes. Recently implemented in the Netherlands, this workflow aims to stratify germline testing while providing information on the effectiveness of PARP inhibitor therapy.
Vera M. Witjes   +50 more
wiley   +1 more source

Home - About - Disclaimer - Privacy